Felice Petraglia

Active 1982–2025

204
Papers
24,817
Citations
90
h-index
194
i10-index

Citations

Citations per year for Felice Petraglia1976: 1 citations1983: 1 citations1984: 2 citations1985: 8 citations1986: 6 citations1987: 12 citations1988: 15 citations1989: 30 citations1990: 36 citations1991: 37 citations1992: 23 citations1993: 24 citations1994: 29 citations1995: 50 citations1996: 25 citations1997: 41 citations1998: 70 citations1999: 81 citations2000: 85 citations2001: 109 citations2002: 88 citations2003: 72 citations2004: 83 citations2005: 100 citations2006: 82 citations2007: 54 citations2008: 49 citations2009: 65 citations2010: 81 citations2011: 77 citations2012: 93 citations2013: 98 citations2014: 143 citations2015: 164 citations2016: 146 citations2017: 153 citations2018: 127 citations2019: 532 citations2020: 737 citations2021: 696 citations2022: 628 citations2023: 513 citations2024: 871 citations2025: 395 citations2026: 7 citations1977–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,656 citing papers, 21.7% of this breakdownChina: 795 citing papers, 10.4% of this breakdownItaly: 648 citing papers, 8.5% of this breakdownUnited Kingdom: 526 citing papers, 6.9% of this breakdownAustralia: 274 citing papers, 3.6% of this breakdownCanada: 266 citing papers, 3.5% of this breakdownFrance: 243 citing papers, 3.2% of this breakdownGermany: 219 citing papers, 2.9% of this breakdownNetherlands: 171 citing papers, 2.3% of this breakdownSpain: 168 citing papers, 2.2% of this breakdownBelgium: 160 citing papers, 2.1% of this breakdownBrazil: 157 citing papers, 2.1% of this breakdown
0%21.7%Other 30.6%

Fields

  • Medicine77.3%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Neuroscience7.3%
  • Immunology and Microbiology3.8%
  • Psychology1.4%
  • Environmental Science0.6%
  • Other1.8%

Topics

  • Endometriosis Research and Treatment10.8%
  • Uterine Myomas and Treatments6%
  • Ovarian function and disorders5.8%
  • Reproductive System and Pregnancy5.7%
  • Reproductive Biology and Fertility3.4%
  • Gynecological conditions and treatments3.1%
  • Other65.2%

Coauthors

All papers

Open in search
  1. Hormonal treatments for endometriosis: The endocrine background

    Authors: , , , - Reviews in Endocrine and Metabolic Disorders 2021 cited by 303

  2. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

    Authors: , , , , , , , , , , , , , , , , , , - Fertility and Sterility 2011 cited by 1,981

  3. Diagnosing adenomyosis: an integrated clinical and imaging approach

    Authors: , , , , , , , , , , , , - Human Reproduction Update 2020 cited by 398

  4. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome

    Authors: , , , , , , - Human Reproduction Update 2015 cited by 378

  5. Adenomyosis: Mechanisms and Pathogenesis

    Authors: , , , - Seminars in Reproductive Medicine 2020 cited by 278

  6. Endometriosis: Cellular and Molecular Mechanisms Leading to Fibrosis

    Authors: , , , , , - Reproductive Sciences 2022 cited by 119

  7. Pathogenesis of adenomyosis: an update on molecular mechanisms

    Authors: , , , , , , - Reproductive BioMedicine Online 2017 cited by 321

  8. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes

    Authors: , , , , , , , , , - Human Reproduction 2017 cited by 288

  9. Genetic, hormonal and metabolic aspects of PCOS: an update

    Authors: , , , , , - Reproductive Biology and Endocrinology 2016 cited by 476

  10. Dysmenorrhea and related disorders

    Authors: , , , , - F1000Research 2017 cited by 364

  11. Inflammation and Pregnancy

    Authors: , , , , , - Reproductive Sciences 2009 cited by 895

  12. Recent advances in understanding and managing adenomyosis

    Authors: , - F1000Research 2019 cited by 276

  13. Role of medical therapy in the management of uterine adenomyosis

    Authors: , , , , - Fertility and Sterility 2018 cited by 229

  14. Activin A in Mammalian Physiology

    Authors: , , , , , - Physiological Reviews 2018 cited by 202

  15. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure

    Authors: , , , , , - Human Reproduction Update 2020 cited by 158

  16. The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis

    Authors: , , , , , - Reproductive Sciences 2022 cited by 95

  17. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics

    Authors: , , , , - Human Reproduction Update 2017 cited by 323

  18. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey

    Authors: , , , , , - International Journal of Gynecology & Obstetrics 2014 cited by 291

  19. Immunological changes associated with adenomyosis: a systematic review

    Authors: , , , , , , , , - Human Reproduction Update 2020 cited by 174

  20. Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management

    Authors: , , , , , - Human Reproduction Update 2015 cited by 393

  21. Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis

    Authors: , , - Human Reproduction Update 2013 cited by 269

  22. Pathogenetic Mechanisms of Deep Infiltrating Endometriosis

    Authors: , , , , - Reproductive Sciences 2015 cited by 217

  23. Transvaginal sonographic features of diffuse adenomyosis in 18–30‐year‐old nulligravid women without endometriosis: association with symptoms

    Authors: , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2015 cited by 204

  24. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials

    Authors: , , , , , , , , , , , , , , - The Lancet 2022 cited by 72